Literature DB >> 4380481

Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action.

P M Lish, J A Labudde, E L Peters, S I Robbins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4380481

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN： 0003-9780


× No keyword cloud information.
  7 in total

1.  Management of overactive bladder with transdermal oxybutynin.

Authors:  Jonathan S Starkman; Roger R Dmochowski
Journal:  Rev Urol       Date:  2006

2.  Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.

Authors:  S E Jones; L M Shuba; P Zhabyeyev; J R McCullough; T F McDonald
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  The use of oxybutynin in urological practice.

Authors:  Z Kirkali; R H Whitaker
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

Review 4.  Oxybutynin: past, present, and future.

Authors:  Kelly Jirschele; Peter K Sand
Journal:  Int Urogynecol J       Date:  2012-09-14       Impact factor: 2.894

5.  Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers.

Authors:  R H Zobrist; B Schmid; A Feick; D Quan; S W Sanders
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

Review 6.  Current concepts in the treatment of disorders of micturition.

Authors:  K E Andersson
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

7.  The pharmacokinetics of oxybutynin in man.

Authors:  J Douchamps; F Derenne; A Stockis; D Gangji; M Juvent; A Herchuelz
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.